Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks

计划入组 1,000 人 · 首次发布于 2021 年 8 月 19 日

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

计划入组 1,100 人 · 首次发布于 2023 年 10 月 23 日

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)

计划入组 15 人 · 首次发布于 2020 年 3 月 31 日

Baloxavir

C₂₄H₁₉F₂N₃O₄S

Baloxavir marboxil(Xofluza)

C₂₇H₂₃F₂N₃O₇S · Rx

NanoViricides' NV-387 Shows Broad-Spectrum Antiviral Activity Against 'Tripledemic' Viruses and Smallpox in Animal Models

CDSCO Panel Mandates Phase III Trial of Baloxavir Marboxil in Indian Population

Single-Dose Baloxavir Significantly Reduces Household Influenza Transmission in Global Phase III Trial